Moderna Inks Deal with U.S. for 100 Million Doses of Vaccine
- Posted by ISPE Boston
- On August 13, 2020
The U.S. government has secured 100 million doses of Moderna’s vaccine candidate mRNA-1273 as part of the goal of securing early access to safe and effective COVID-19 vaccines for the American people. The award of up to $1.525 billion is for the manufacturing and delivery of 100 million doses of mRNA-1273 including incentive payments for timely delivery of the product. […]
Read More